Increasing adiponectin levels is an important therapeutic goal given that it improves insulin sensitivity, reduces inflammation, and improves metabolic function in obesity models (Xu et al, 2003; Kim et al, 2007; Gastaldelli et al, 2010; Phillips & Kung, 2010). This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.